Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1022820120030010013
Journal of Multiple Sclerosis and Neuroimmunology
2012 Volume.3 No. 1 p.13 ~ p.19
Update of Multiple jSclerosis
Kim Sun-Young

Abstract
In the last decade of the 20th century, the development of pharmacological agents for MS paralleled advances in the understanding of disease pathophysiology, in neuroimmunology, and in neuroimaging. Although MS was previously thought to be primarily a disease of CNS myelin, recent neuropathologic studies have confirmed the evidence of axonal injury in both the early and late stages of the illness. The knowledge about early intervention leads us to revise the diagnostic criteria for MS, which should be required to prevent further axonal damage. Consequently, this article will provide a general overview of MS, focusing on current concepts of diagnostic criteria, pathology/pathogenesis, and risk factors.
KEYWORD
Mutiple sclerosis, MGNIMS criteria, Cortical pathology, Chronic venous insufficiency
FullTexts / Linksout information
Listed journal information